1. Home
  2. AMCX vs CTNM Comparison

AMCX vs CTNM Comparison

Compare AMCX & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMCX
  • CTNM
  • Stock Information
  • Founded
  • AMCX 1980
  • CTNM 2009
  • Country
  • AMCX United States
  • CTNM United States
  • Employees
  • AMCX 1800
  • CTNM N/A
  • Industry
  • AMCX Cable & Other Pay Television Services
  • CTNM
  • Sector
  • AMCX Telecommunications
  • CTNM
  • Exchange
  • AMCX Nasdaq
  • CTNM Nasdaq
  • Market Cap
  • AMCX 339.5M
  • CTNM 328.1M
  • IPO Year
  • AMCX 2011
  • CTNM 2024
  • Fundamental
  • Price
  • AMCX $7.77
  • CTNM $10.69
  • Analyst Decision
  • AMCX Sell
  • CTNM Strong Buy
  • Analyst Count
  • AMCX 4
  • CTNM 5
  • Target Price
  • AMCX $6.38
  • CTNM $22.20
  • AVG Volume (30 Days)
  • AMCX 381.5K
  • CTNM 106.2K
  • Earning Date
  • AMCX 11-07-2025
  • CTNM 10-30-2025
  • Dividend Yield
  • AMCX N/A
  • CTNM N/A
  • EPS Growth
  • AMCX N/A
  • CTNM N/A
  • EPS
  • AMCX N/A
  • CTNM N/A
  • Revenue
  • AMCX $2,316,303,000.00
  • CTNM N/A
  • Revenue This Year
  • AMCX N/A
  • CTNM N/A
  • Revenue Next Year
  • AMCX N/A
  • CTNM N/A
  • P/E Ratio
  • AMCX N/A
  • CTNM N/A
  • Revenue Growth
  • AMCX N/A
  • CTNM N/A
  • 52 Week Low
  • AMCX $5.41
  • CTNM $3.35
  • 52 Week High
  • AMCX $10.60
  • CTNM $19.21
  • Technical
  • Relative Strength Index (RSI)
  • AMCX 52.46
  • CTNM 46.61
  • Support Level
  • AMCX $6.98
  • CTNM $10.07
  • Resistance Level
  • AMCX $8.40
  • CTNM $11.75
  • Average True Range (ATR)
  • AMCX 0.34
  • CTNM 0.71
  • MACD
  • AMCX 0.06
  • CTNM -0.01
  • Stochastic Oscillator
  • AMCX 54.22
  • CTNM 37.50

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: